Chief Executive OfficerDave Marver joined ONWARD in July 2020. An accomplished chief executive and director with more than 25 years of international experience in public, private, and emerging companies, he combines expertise in medical and consumer technology, wearables, and health monitoring. Previously, Dave spent almost 15 years with Medtronic in a variety of leadership positions in the US and Europe, including Vice President roles in Sales, Marketing, Strategy, and Business Development. He then joined NASDAQ-listed Cardiac Science Corporation as CEO, before co-founding two start-ups. He holds a BA in Psychology from Duke University and an MBA from University of California Los Angeles.
John Murphy, PhD
Chief Technology OfficerJohn Murphy has over 25 years of experience driving the development of medical implants and neurostimulation devices at LivaNova, Abbott, and Medtronic. His leadership expertise spans the continuum of R&D, with a focus on consumer-centric design, IP generation, and agile processes. Prior to joining ONWARD in 2020, John was the Chief Technology Officer of LivaNova Neuromodulation. He holds a BS in Electrical Engineering from the University of North Carolina at Charlotte and a PhD in Production Systems and Robotics from the Swiss Federal Institute of Technology (EPFL).
Grégoire Courtine, PhD
Chief Scientific OfficerProf. Grégoire Courtine is the co-founder of ONWARD and its Chief Scientific Officer as well as a Non-Executive Director. His ground-breaking research in neuroscience has been recognized by several prestigious prizes, including the Rolex Award, the Schellenberg Research Prize and the Chancellor’s Award of the University of California. Grégoire is a full professor of neuroscience and neurotechnology at the Swiss Federal Institute of Technology (EPFL) and Director of NeuroRestore, a research center at EPFL and the University Hospital of Lausanne that develops innovative therapies using neurostimulation and other approaches. He holds a PhD in Neurosciences from INSERM, Paris, and a PhD in Medicine from the University of Pavia, Italy.
Chief Financial OfficerMarko Jansen’s experience in financial management spans 25 years in both multinational companies and innovative startups. Building on his extensive expertise in financial analysis and agile project management, Marko has served as the company’s CFO since 2017. Prior to that, he held senior positions at Audionova International B.V., a hearing aid company, and nVent Erico, a global electrical equipment manufacturer. Marko began his career in public accounting with Arthur Andersen. He is a licensed CPA and holds a BA in Accounting and a PhD in Business Economics from the University of Tilburg.
Vincent Delattre, PhD
Vice President, Business DevelopmentVincent Delattre co-founded ONWARD in 2014 and currently oversees the company’s extensive IP portfolio and business development activities. Vincent combines expertise in science and business management: he has led pioneering research on electrical stimulation and neural circuit reorganisation and has been recognized by several business prizes, including Hello Tomorrow, Venture Best Business Idea, and the Wellcome Trust Award. He previously served as the company’s CEO and Chief Technology Officer. Vincent holds a PhD in Neurosciences from the Swiss Federal Institute of Technology (EPFL), Lausanne.
Hendrik Lambert, PhD
Vice-President, Clinical & RegulatoryHendrik Lambert has over 20 years of experience in leading clinical and regulatory strategies for high-risk (Class III) medical devices in both Europe and the US, from initial design to market approval. Before joining ONWARD in 2015, Hendrik was Vice President for Clinical and Regulatory Affairs at Endosense, a Geneva-based medtech company developing innovative products for the cardiology market, which was acquired by St. Jude Medical. He holds a PhD in Biomedical Engineering from the University of Ghent, Belgium.
Managing Director USADavid Harari is a talented scientific leader with 30 years of experience in the clinical and regulatory management of medical devices, from initial concept to commercialization. Before joining ONWARD in 2019 to lead its US affiliate, David held senior positions in clinical affairs with Guidant, Boston Scientific, Endosense, St Jude Medical, and Vytronus Inc. He holds a BS in Engineering Sciences and Biomedical Engineering from the University of Michigan.
Global HR DirectorRano Burkhanova is an accomplished talent development executive with 15 years of experience with multinational companies in the US and the Netherlands. Before joining ONWARD in 2020, Rano managed leadership development, gender diversity, and engagement programs for Danone Nutrition, Elsevier, and Medtronic. She holds an MA in human Resources Management from Cornell University and an MBA from the Quantic School of Science and Technology.
Vice President, MarketingAndy Dolan has 20 years of experience in marketing, business development, and organizational leadership for medical device companies, both private and public. Before joining ONWARD in 2021, Andy held senior roles in sales and marketing at ReWalk Robotics, Boston Scientific, Johnson & Johnson and Integra LifeSciences. He holds an MBA from the University of Massachusetts and a graduate certificate in bioengineering from Tufts University. He also serves as a United States Navy Reserve Public Affairs Officer.
Chief of StaffDoina Cebotari joined ONWARD in 2021 after an impressive career focused on consulting and public service. Doina began her career at the World Bank, then served as an Advisor to the Prime Minister of Moldova. She later spent several years at McKinsey & Company as a consultant and later joined Expedia Group, working on strategic initiatives. Doina holds a BA in Philosophy, Politics and Economics from Oxford University, an MA in International Economics and Development from the School of Advanced International Studies (SAIS) at Johns Hopkins University, and an MBA from INSEAD.